• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生物标志物诱导针对二十二碳六烯酸纳米囊泡包裹的重组乙肝表面抗原蛋白的天然免疫和适应性免疫反应。

Induction of Innate and Adaptive Immune Response against Recombinant HBsAg Protein Entrapped in Docosahexaenoic Acid Nanovesicles through Biomarkers.

作者信息

Bakkari Mohammed Ali, Moni Sivakumar S, Alshammari Abdulrahman, Sultan Muhammad H, Madkhali Osama A, Almoshari Yosif, Alam Mohammad Firoz, Elmobark Mohamed Eltaib

机构信息

Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.

Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

出版信息

Vaccines (Basel). 2023 Feb 16;11(2):457. doi: 10.3390/vaccines11020457.

DOI:10.3390/vaccines11020457
PMID:36851333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9958728/
Abstract

The present study focused on demonstrating the induction of humoral and cell-mediated immunity through the establishment of a cytokine network. We hypothesized the anti-inflammatory, pro-inflammatory, and IgE antibody levels after vaccination with lyophilized recombinant HBsAg-loaded docosahexaenoic acid nanovesicles (LRPDNV), and the efficacy compared well with standard commercial recombinant hepatitis B vaccine. The cytokine network was efficiently regulated by striking a balance between pro-inflammatory cytokines IL-6, IL-8R, and IL-12 and anti-inflammatory cytokines such as IL-2, IL-4, IL-10, and IFN-γ immune response on the 14 and 30 day after primary and booster immunization. The acute phase protein CRP level was increased due to IL-6 after immunizing with LRPDNV. On the other hand, the IgE level was not significantly increased to induce any allergic reactions after immunization with LRPDNV. The study concluded that after immunizing with LRPDNV, a significant immunological response was established, implying that DHA nanovesicles have significant potential as an adjuvant method for delivering recombinant HBsAg protein. On the other hand, following immunization with LRPDNV, the IgE level was not noticeably elevated enough to cause any adverse reactions. The study concludes that a robust immune response was developed after immunizing with LRPDNV and suggests that DHA nanovesicles have much potential to deliver recombinant HBsAg protein.

摘要

本研究着重通过建立细胞因子网络来证明体液免疫和细胞介导免疫的诱导。我们假设冻干的负载重组乙肝表面抗原的二十二碳六烯酸纳米囊泡(LRPDNV)接种疫苗后抗炎、促炎和IgE抗体水平,且其效果与标准商业重组乙肝疫苗相当。在初次免疫和加强免疫后的第14天和第30天,通过在促炎细胞因子IL-6、IL-8R和IL-12与抗炎细胞因子如IL-2、IL-4、IL-10和IFN-γ免疫反应之间取得平衡,有效地调节了细胞因子网络。用LRPDNV免疫后,由于IL-6,急性期蛋白CRP水平升高。另一方面,用LRPDNV免疫后,IgE水平没有显著升高以诱导任何过敏反应。该研究得出结论,用LRPDNV免疫后,建立了显著的免疫反应,这意味着DHA纳米囊泡作为递送重组乙肝表面抗原蛋白的佐剂方法具有巨大潜力。另一方面,用LRPDNV免疫后,IgE水平没有明显升高到足以引起任何不良反应的程度。该研究得出结论,用LRPDNV免疫后产生了强烈的免疫反应,并表明DHA纳米囊泡在递送重组乙肝表面抗原蛋白方面有很大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/727cdfa1c175/vaccines-11-00457-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/3d7e3c1012bf/vaccines-11-00457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/7c92963a8b99/vaccines-11-00457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/6f4af6a05950/vaccines-11-00457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/8bc123b0785d/vaccines-11-00457-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/02fba2f40b89/vaccines-11-00457-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/56a49a60bc1b/vaccines-11-00457-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/132a34bed12d/vaccines-11-00457-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/727cdfa1c175/vaccines-11-00457-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/3d7e3c1012bf/vaccines-11-00457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/7c92963a8b99/vaccines-11-00457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/6f4af6a05950/vaccines-11-00457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/8bc123b0785d/vaccines-11-00457-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/02fba2f40b89/vaccines-11-00457-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/56a49a60bc1b/vaccines-11-00457-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/132a34bed12d/vaccines-11-00457-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc86/9958728/727cdfa1c175/vaccines-11-00457-g008.jpg

相似文献

1
Induction of Innate and Adaptive Immune Response against Recombinant HBsAg Protein Entrapped in Docosahexaenoic Acid Nanovesicles through Biomarkers.通过生物标志物诱导针对二十二碳六烯酸纳米囊泡包裹的重组乙肝表面抗原蛋白的天然免疫和适应性免疫反应。
Vaccines (Basel). 2023 Feb 16;11(2):457. doi: 10.3390/vaccines11020457.
2
Design, Characterization, and Immune Augmentation of Docosahexaenoic Acid Nanovesicles as a Potential Delivery System for Recombinant HBsAg Protein.二十二碳六烯酸纳米囊泡作为重组乙肝表面抗原蛋白潜在递送系统的设计、表征及免疫增强作用
Vaccines (Basel). 2022 Jun 16;10(6):954. doi: 10.3390/vaccines10060954.
3
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.人类接种含佐剂乙肝疫苗后与全身反应原性相关的炎症参数。
Vaccine. 2019 Mar 28;37(14):2004-2015. doi: 10.1016/j.vaccine.2019.02.015. Epub 2019 Mar 5.
4
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.含有单磷酰脂质A和QS-21的疫苗佐剂系统可诱导针对乙肝表面抗原的强烈体液免疫和细胞免疫反应,且在接种疫苗后至少持续4年。
Vaccine. 2015 Feb 18;33(8):1084-91. doi: 10.1016/j.vaccine.2014.10.078. Epub 2014 Nov 7.
5
Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses.蒙坦尼德 ISA-720 佐剂与纳洛酮在 HBsAg 疫苗配方中的应用:细胞因子谱分析及长效体液免疫应答监测。
Biomed Environ Sci. 2022 Sep 20;35(9):792-803. doi: 10.3967/bes2022.104.
6
Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.桔梗皂苷D是针对重组乙肝抗原的特异性细胞免疫和体液免疫反应的有效佐剂。
Vaccine. 2009 Jan 29;27(5):757-64. doi: 10.1016/j.vaccine.2008.11.029. Epub 2008 Nov 27.
7
RLJ-NE-299A: a new plant based vaccine adjuvant.RLJ-NE-299A:一种新型植物源疫苗佐剂。
Vaccine. 2007 Mar 30;25(14):2706-15. doi: 10.1016/j.vaccine.2006.06.036. Epub 2006 Jul 10.
8
Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.在小鼠模型中,口服合成硒纳米颗粒在乙肝表面抗原疫苗接种后诱导出强烈的Th1细胞因子模式。
J Infect Public Health. 2017 Jan-Feb;10(1):102-109. doi: 10.1016/j.jiph.2016.02.006. Epub 2016 Mar 23.
9
Immunization of Experimental Dogs With Salivary Proteins From , Using DNA and Recombinant Canarypox Virus Induces Immune Responses Consistent With Protection Against .用 DNA 和重组金丝雀痘病毒对实验犬进行唾液蛋白免疫接种可诱导针对 的免疫应答,与预防 的作用一致。
Front Immunol. 2018 Nov 16;9:2558. doi: 10.3389/fimmu.2018.02558. eCollection 2018.
10
Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.肝移植受者的乙型肝炎疫苗接种:细胞免疫反应的初步分析显示存在HBsAg特异性调节性T细胞的证据。
Liver Transpl. 2007 Mar;13(3):434-42. doi: 10.1002/lt.21061.

引用本文的文献

1
Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations.疫苗佐剂的进展:从明矾到纳米制剂的历程
Vaccines (Basel). 2023 Nov 9;11(11):1704. doi: 10.3390/vaccines11111704.
2
Design and characterization of Lactotransferrin peptide-loaded dextran-docosahexaenoic acid nanoparticles: an immune modulator for hepatic damage.载乳铁传递蛋白肽的葡聚糖-二十二碳六烯酸纳米粒的设计与表征:一种肝脏损伤的免疫调节剂。
Sci Rep. 2023 Aug 19;13(1):13537. doi: 10.1038/s41598-023-40674-9.

本文引用的文献

1
Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus.乙型肝炎病毒治疗与肝细胞癌:争议与共识达成途径
Liver Cancer. 2022 Aug 23;11(6):497-510. doi: 10.1159/000525518. eCollection 2022 Dec.
2
Global burden of primary liver cancer in 2020 and predictions to 2040.2020 年全球原发性肝癌负担及 2040 年预测。
J Hepatol. 2022 Dec;77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021. Epub 2022 Oct 5.
3
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
4
Design, Characterization, and Immune Augmentation of Docosahexaenoic Acid Nanovesicles as a Potential Delivery System for Recombinant HBsAg Protein.二十二碳六烯酸纳米囊泡作为重组乙肝表面抗原蛋白潜在递送系统的设计、表征及免疫增强作用
Vaccines (Basel). 2022 Jun 16;10(6):954. doi: 10.3390/vaccines10060954.
5
Persistence of Immunity in Adults after 1, 5 and 10 Years with Recombinant Hepatitis B Vaccine in Beijing in 2010-2020.2010 - 2020年北京成人接种重组乙型肝炎疫苗1年、5年和10年后的免疫持久性
Vaccines (Basel). 2022 Jan 25;10(2):181. doi: 10.3390/vaccines10020181.
6
Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24CD38 Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders.乙肝疫苗无应答者与应答者相比,CD24CD38 调节性 B 细胞频率更高,IL-10 表达水平更低。
Front Immunol. 2021 Sep 10;12:713351. doi: 10.3389/fimmu.2021.713351. eCollection 2021.
7
Immunosuppressive Mechanisms of Regulatory B Cells.调节性 B 细胞的免疫抑制机制。
Front Immunol. 2021 Apr 29;12:611795. doi: 10.3389/fimmu.2021.611795. eCollection 2021.
8
Emerging concepts in the science of vaccine adjuvants.疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
9
Roles of IFN-γ in tumor progression and regression: a review.γ干扰素在肿瘤进展与消退中的作用:综述
Biomark Res. 2020 Sep 29;8:49. doi: 10.1186/s40364-020-00228-x. eCollection 2020.
10
Genetic variation in IL-10 influences the progression of hepatitis B infection.白细胞介素-10(IL-10)基因变异影响乙型肝炎感染的进展。
Int J Infect Dis. 2020 Jul;96:260-265. doi: 10.1016/j.ijid.2020.04.079. Epub 2020 May 6.